ALSO READAbbott gets NPPA nod to withdraw premium stent from India Abbott to discontinue sales of fully biodegradable stent Abbott likely to launch second-generation Falcon stent Govt asks stent makers to maintain supply of coronary stents Hospitals charging over 500% for angioplasty devices: Maharashtra FDA
The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed today.
The government has fixed the ceiling prices of 849 formulations, including two coronary stents, under revised Schedule I, based on National List of Essential Medicines, 2015," Minister of State for Chemicals & Fertilisers Mansukh L Mandaviya said in a written reply in Rajya Sabha.
The National Pharmaceuticals Pricing Authority (NPPA) fixes the ceiling prices of medicines listed in the Drugs (Prices Control) Order, 2013 (DPCO 2013), he added.
Out of the 849 formulations, the ceiling prices of 59 formulations were reduced by above 40 per cent with respect to maximum price, Mandaviya said.
In case of 24 formulations, the slab wise percentage reduction with respect to maximum price was between 35-40 per cent, he added.
The prices of 233 formulations were reduced by up to five per cent, Mandaviya said.